论文部分内容阅读
目的:探讨氨溴索联合沙丁胺醇吸入治疗慢性阻塞性肺疾病(COPD)的临床疗效。方法:选择社区医院治疗的急性期COPD患者100例,将其平均分为研究组与对照组。研究组应用沙丁胺醇+氨溴索+氯化钠吸入治疗,对照组应用沙丁胺醇+氯化钠吸入治疗。结果:研究组治疗的总有效率为96.00%,显著高于对照组的80.00%(P<0.05)。两组不良反应症状均较轻微,未采取任何干预措施,自行缓解。结论:氨溴索联合沙丁胺醇吸入治疗COPD,疗效确切,可以有效改善患者的临床症状,安全可靠,适于推广。
Objective: To investigate the clinical efficacy of ambroxol combined with salbutamol inhalation in the treatment of chronic obstructive pulmonary disease (COPD). Methods: A total of 100 acute COPD patients treated in community hospital were selected and divided equally into study group and control group. The study group received salbutamol + ambroxol + sodium chloride inhalation, while the control group received salbutamol + sodium chloride inhalation. Results: The total effective rate of the study group was 96.00%, which was significantly higher than that of the control group (80.00%, P <0.05). Two groups of adverse reactions were mild symptoms, did not take any interventions to ease themselves. Conclusion: Ambroxol combined with albuterol inhalation for the treatment of COPD has definite curative effect and can effectively improve the clinical symptoms of patients. It is safe and reliable and is suitable for promotion.